Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-14-001993

Options or other derivatives

  • Director acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dabney Reid J D · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-06-18 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +80,000 $1.25 2024-06-18 80,000 630,200 D
Loading xslF345X03/form4-06272014_010614.xml…